University Officials Struggle To Find True Price Of Science

Indirect costs scandals and a new federal mandate pressure budget officers to grapple with what they see as a befuddling to grapple with what they see as a befuddling task WASHINGTON--University research administrators across the United States are moving to comply with a newly imposed limit on how much money they can recover from the government to compensate their schools for administrative support of federally funded research. And in the process of observing the new federal regulation,

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Indirect costs scandals and a new federal mandate pressure budget officers to grapple with what they see as a befuddling to grapple with what they see as a befuddling task

WASHINGTON--University research administrators across the United States are moving to comply with a newly imposed limit on how much money they can recover from the government to compensate their schools for administrative support of federally funded research.

And in the process of observing the new federal regulation, some of these administrators are becoming frustrated by what they see as a fundamental flaw in the system of indirect costs recovery--namely, the lack of consensus on how to calculate the real cost of research at their institutions.

"For all the accounting that goes into it, it's still not a precise science," says Marvin Ebel, a physicist and associate dean of the graduate school at the University of Wisconsin, Madison, referring to the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo